John Oyler Biography and Net Worth

CEO of BeOne Medicines

John V. Oyler co-founded BeiGene in 2010. He has served as CEO and has led the Board of Directors from the company’s start.

Mr. Oyler previously served as President and CEO of BioDuro, LLC, a drug discovery services company, from 2005 its acquisition by PPD in 2009. From 2002 to 2004, Mr. Oyler served as CEO of Galenea Corp., a biopharmaceutical company discovering novel therapies for central nervous system diseases. From 1998 to 2002, Mr. Oyler was the President of Telephia, Inc., an information company he founded and ultimately was acquired by The Nielsen Company. From 1997 to 1998, Mr. Oyler was Co-Chief Executive Officer of Genta Incorporated (NASDAQ: GNTA), an oncology-focused biopharmaceutical company. He began his career as a management consultant at McKinsey & Company.

Mr. Oyler served on the Board of Directors of the Biotechnology Innovation Organization (BIO) from 2019-2024. He also serves on the Stanford Graduate School of Business Advisory Council. Mr. Oyler received his B.S. in mechanical engineering from the Massachusetts Institute of Technology and an MBA from Stanford University. A native of Pittsburgh, he is an avid fan of the city’s Steelers football team and Penguins hockey team, and enjoys skiing and spending time with his family.

What is John Oyler's net worth?: The estimated net worth of John Oyler is at least $551.92 thousand as of June 16th, 2026. Oyler owns 2,043 shares of BeOne Medicines stock worth more than $551,916 as of June 20th. This net worth evaluation does not reflect any other assets that Oyler may own. Learn More about John Oyler's net worth.
How do I contact John Oyler?: The corporate mailing address for Oyler and other BeOne Medicines executives is C/O MOURANT GOVERNANCE SERVICES (CAYMAN), 94 SOLARIS AVENUE, CAMANA BAY, GRAND CAYMAN, E9, KY1-1108. BeOne Medicines can also be reached via phone at 13459494123 and via email at [email protected]. Learn More on John Oyler's contact information.
Has John Oyler been buying or selling shares of BeOne Medicines?: During the last quarter, John Oyler has sold $2,818,603.31 in BeOne Medicines stock. Most recently, John Oyler sold 3,693 shares of the business's stock in a transaction on Tuesday, June 16th. The shares were sold at an average price of $265.55, for a transaction totalling $980,676.15. Following the completion of the sale, the chief executive officer now directly owns 2,043 shares of the company's stock, valued at $542,518.65. Learn More on John Oyler's trading history.
Who are BeOne Medicines' active insiders?: BeOne Medicines' insider roster includes Margaret Dugan (Director), Chan Lee (SVP), John Oyler (CEO), Alessandro Riva (Director), Aaron Rosenberg (CFO), Corsee Sanders (Director), Corsee Sanders (Director), Lai Wang (Global Head of R&D), Lai Wang (Insider), Xiaodong Wang (Insider), and Xiaobin Wu (COO). Learn More on BeOne Medicines' active insiders.
Are insiders buying or selling shares of BeOne Medicines?: In the last twelve months, insiders at the sold shares 51 times. They sold a total of 351,635 shares worth more than $108,128,931.49. The most recent insider tranaction occured on June, 16th when COO Xiaobin Wu sold 1,357 shares worth more than $361,993.32. Insiders at BeOne Medicines own 6.2% of the company. Learn More about insider trades at BeOne Medicines.
Information on this page was last updated on 6/16/2026.

John Oyler Insider Trading History at BeOne Medicines

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/16/2026	Sell	3,693	$265.55	$980,676.15	2,043
6/11/2026	Sell	1,949	$257.24	$501,360.76	5,697,649
6/8/2026	Sell	4,940	$270.56	$1,336,566.40	1,120
12/16/2025	Sell	24,369	$302.87	$7,380,639.03
12/15/2025	Sell	75,631	$307.79	$23,278,465.49	24,369
9/16/2025	Sell	27,803	$325.71	$9,055,715.13
7/9/2025	Sell	27,802	$253.38	$7,044,470.76
6/23/2025	Sell	3,174	$261.61	$830,350.14
6/17/2025	Sell	1,460	$256.49	$374,475.40
6/16/2025	Sell	3,680	$266.05	$979,064.00	1,460
6/6/2025	Sell	5,127	$252.77	$1,295,951.79
3/7/2025	Sell	58,590	$249.13	$14,596,526.70
3/3/2025	Sell	101,000	$244.30	$24,674,300.00

John Oyler Buying and Selling Activity at BeOne Medicines

BeOne Medicines Company Overview

BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.

Today's Range

Now: $270.15

$265.02

$274.55

50 Day Range

MA: $295.32

$260.27

$323.87

2 Week Range

Now: $270.15

$239.25

$385.22

Volume

367,884 shs

Average Volume

276,998 shs

Market Capitalization

$29.64 billion

P/E Ratio

60.44

Dividend Yield

N/A

Beta

0.49